Anecdotal reports have suggested that the use and abuse of methamphetamine is increasing in the United States. To date, however, few scholarly works have explored the prevalence and correlates of methamphetamine use in the United States. To address this limitation, a secondary analysis was undertaken with data collected through the Arrestee Drug Abuse Monitoring (ADAM) Program. An examination of methamphetamine-positive rates among ADAM arrestees interviewed between 1991 and 2001 identified that its use is concentrated within the Western part of the United States. Supplementary analyses of Sacramento arrestees indicated that 71% were diagnosed as needing some form of alcohol or other drug treatment. Compared to those arrestees who were detected methamphetamine-negative, methamphetamine-positive arrestees in Sacramento were three times as likely to be white and to have been diagnosed in need of drug treatment. Implications for drug control policy are discussed.
Get full access to this article
View all access options for this article.
References
1.
AnglinM. D.BurkeC.PerrochetB.StamperE., and Dawud-NoursiS., History of the Methamphetamine Problem, Journal of Psychoactive Drugs, 32, pp. 137–141, 2002.
2.
United States Department of Justice, COPS Fact Sheet: COPS Methamphetamine Funding, U.S. Department of Justice, Washington, D.C., 2002.
3.
EganT., Pastoral Poverty: The Seeds of Decline, New York Times, December 8, 2002.
4.
National Institute on Drug Abuse, Methamphetamine Abuse and Addiction (NIH Publication Number 02–4210), National Institutes on Health, Bethesda, Maryland, 2002.
5.
ChoA. K. and MelegaW. P., Patterns of Methamphetamine Abuse and Their Consequences, Journal of Drug Education, 21, pp. 21–34, 2002.
6.
RawsonR. A.AnglinM. D., and LingW., Will the Methamphetamine Problem Go Away?Journal of Addictive Diseases, 21, pp. 5–19, 2002.
7.
SimonS. L.RichardsonK.DaceyJ.GlynnS.DomierC. P.RawsonR. A., and LingW., Comparison of Patterns of Methamphetamine and Cocaine Use, Journal of Addictive Diseases, 21, pp. 35–44, 2002.
8.
WermuthL., Methamphetamine Use: Hazards and Social Influences, Journal of Drug Education, 30, pp. 423–433, 2000.
9.
SneiderD., Methamphetamine Use is Spreading, In Illegal Drugs: Current Controversies, CozicC. P. (Ed.), Greenhaven Press, Inc., San Diego, California, 1998.
10.
MieczkowskiT.BarzelayD.GropperB., and WishE. D., Concordance of Three Measures of Cocaine Use in an Arrestee Population: Hair, Urine, and Self-Report, Journal of Psychoactive Drugs, 23, pp. 241–246, 1991.
11.
YacoubianG., Reassessing the Need for Urinalysis as a Validation Technique, Journal of Drug Issues, 30, pp. 323–334, 2000.
12.
Substance Abuse and Mental Health Services Administration, Results from the 2002 National Survey on Drug Use and Health: National Findings, U.S. Department of Health and Human Services, Rockville, Maryland, 2003.
13.
Substance Abuse and Mental Health Services Administration, Mortality Data from the Drug Abuse Warning Network, 2001, U.S. Department of Health and Human Services, Rockville, Maryland, 2003.
14.
Substance Abuse and Mental Health Services Administration, Emergency Department Trends from the Drug Abuse Warning Network, Final Estimates 1995–2002, U.S. Department of Health and Human Services, Rockville, Maryland, 2003.
15.
JohnstonL. D.O'MalleyP. M., and BachmanJ. G., Monitoring the Future National Survey Results on Drug Use, 1975–2002, Volume I: Secondary School Students, National Institute on Drug Abuse, Bethesda, Maryland, 2003.
16.
National Institute of Justice, Arrestee Drug Abuse Monitoring Annual Report, United States Department of Justice, Washington, D.C., 2003.
17.
YacoubianG., Assessing ADAM's Domain: Past, Present, and Future, Contemporary Drug Problems, 27, pp. 121–135, 2000.
18.
YacoubianG., The Sins of ADAM: Toward a New National Criminal Justice Drug Use Surveillance System, International Journal of Drug Testing, 3, Available at: http://www.criminology.fsu.edu/journal/volume3.html, 2004.
19.
National Institute of Justice, 1998 Arrestee Drug Abuse Monitoring (ADAM) Annual Report, United States Department of Justice, Washington, D.C., 1999.
20.
HuntD. and RhodesW., Methodology Guide for ADAM, Abt Associates, Inc., Cambridge, Massachusetts, 2001.
21.
MaguraS. and KangS., Validity of Self-Reported Drug Use in High-Risk Populations: A Meta-Analytical Review, Substance Use and Misuse, 31, pp. 1131–1153, 1996.
22.
YacoubianG.BoyleC. L.HardingC. A., and LoftusE. A., It's a Rave New World: Estimating the Prevalence and Perceived Harm of Ecstasy and Other Drugs among Club Rave Attendees, Journal of Drug Education, 33, pp. 187–196, 2003.
23.
YacoubianG.ArriaA.FostE., and WishE. D., Estimating the Prevalence of Ecstasy Use among Juvenile Offenders, Journal of Psychoactive Drugs, 34, pp. 209–213, 2002.
24.
YacoubianG.DeutschJ., and SchumacherE., Estimating the Prevalence of Ecstasy Use among Club Rave Attendees, Contemporary Drug Problems, 31, pp. 163–177, 2004.
25.
De LeonG., Treatment Strategies, in Handbook of Drug Control in the United States, InciardiJ. A. (ed.), Greenwood Publishing Group, Inc., Westport, Connecticut, pp. 115–138, 1990.
26.
CurrieE., Reckoning: Drugs, the Cities, and the American Failure, Hill and Wang, New York, 1992.
27.
WishE. D.PetronisK. R., and YacoubianG., CADS: Two Short Screeners for Cocaine and Heroin Dependence among Arrestees, Journal of Drug Issues, 32, pp. 907–920, 2002.
28.
National Institute of Justice, NIJ Provides Further Information on ADAM Program Decision, U.S. Department of Justice, Washington, D.C., January 29, 2004.
